Maso Capital Partners Ltd - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 392 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
Maso Capital Partners Ltd ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q4 2020$1,663,000
-47.0%
91,367
-48.0%
0.45%
-74.1%
Q3 2020$3,136,000
-19.3%
175,799
-18.9%
1.75%
+11.8%
Q2 2020$3,887,000
+18.1%
216,7660.0%1.57%
+84.0%
Q1 2020$3,291,000
-8.1%
216,766
+19.3%
0.85%
-26.0%
Q4 2019$3,583,000
+63.0%
181,625
+42.1%
1.15%
+45.8%
Q3 2019$2,198,000
-2.8%
127,7710.0%0.79%
-33.4%
Q2 2019$2,262,000
-14.2%
127,771
-1.2%
1.19%
-34.5%
Q1 2019$2,635,000129,3711.81%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2019
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders